The experimental results demonstrate that a successful activation of immune responses occurs following CDH11 inhibition‐mediated cGAS‐STING activation, in which IFN‐β plays a crucial role in stimulating tumor‐specific T cell response and may act as a mediator between the CDH11 inhibitor and activation of immune responses. The gene discussed is STING1; the disease is neoplasm.